Paradigm Financial Partners LLC cut its position in shares of Edwards Lifesciences Co. (NYSE:EW – Free Report) by 86.8% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 3,308 shares of the medical research company’s stock after selling 21,765 shares during the quarter. Paradigm Financial […]